Home › Asset managers › Compare 2024-2025 › BlackRock vs American Century
BlackRock 2024-2025 · American Century 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 16,281 | 13,640 | 2,268 | 373 | 85.7% | 84.9% |
| Board proposals | 12,314 | 9,994 | 2,043 | 277 | 83.0% | 82.2% |
| E&S shareholder proposals | 234 | 197 | 1 | 36 | 99.5% | 96.1% |
| Other items | 3,733 | 3,449 | 224 | 60 | 93.9% | 93.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,320 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | American Century |
|---|---|---|---|---|---|---|
| AMERICAN FINANCIAL GROUP INC. | May 22, 2025 | Approval of amendment to the Amended and Restated 2015 Stock Incentive Plan solely to add non-employee directors. Compensation |
Board | For | FOR 36 funds |
AGAINST 9 funds |
| AMERICAN HEALTHCARE REIT INC. | June 25, 2025 | To approve the American Healthcare REIT, Inc. 2025 Manager Equity Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 12 funds |
| AMERICAN HEALTHCARE REIT INC. | June 25, 2025 | To approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2024. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 13 funds |
| AMERICAN HOMES 4 RENT | May 7, 2025 | Advisory Vote to Approve American Homes 4 Rent's Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 9 funds |
| AMERICAN INTERNATIONAL GROUP INC. | May 14, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 8 funds |
| AMERICAN PUBLIC EDUCATION INC. | May 23, 2025 | to approve an amendment to the American Public Education, Inc. 2017 Omnibus Incentive Plan to increase the number of shares available for issuance thereunder and to remove the fungible share ratio applied to certain new full-value equity awards. Compensation |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| AMERICAN PUBLIC EDUCATION INC. | May 23, 2025 | to approve, by a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| AMERICAN SOFTWARE INC. | August 20, 2024 | To approve the adoption of the 2024 Equity Compensation Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| AMERICAN SOFTWARE INC. | August 20, 2024 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| AMERICAN W | May 14, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | Not determined | FOR 63 funds |
AGAINST 7 funds |
| AMERICOLD REALTY TRUST | May 20, 2025 | Amend and Restate the Americold Realty Trust 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 27 funds |
AGAINST 5 funds |
| AMERISAFE INC. | June 6, 2025 | To approve an amendment to the Company's Non-Employee Director Restricted Stock Plan to increase the number of authorized shares issuable under the Plan. Compensation |
Board | For | FOR 20 funds |
AGAINST 7 funds |
| AMERISAFE INC. | June 6, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 8 funds |
| AMETEK INC. | May 7, 2025 | Approval, by advisory vote, of the compensation of AMETEK, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 70 funds |
AGAINST 10 funds |
| AMICUS THERAPEUTICS INC. | June 5, 2025 | Approval of the 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 4 funds |
| AMKOR TECHNOLOGY INC. | May 15, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 34 funds |
AGAINST 18 funds |
| AMN HEALTHCARE SERVICES INC. | May 2, 2025 | To approve the AMN Healthcare 2025 Equity Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 5 funds |
| AMNEAL PHARMACEUTICALS INC. | May 6, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 1 fund |
| AMPHENOL CORP. | May 15, 2025 | Advisory vote to approve compensation of named executive officers Shareholder Rights and Defenses |
Board | For | FOR 52 funds |
AGAINST 6 funds |
| AMTECH SYSTEMS INC. | March 5, 2025 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement; and Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ANAPTYSBIO INC. | June 17, 2025 | To approve an amendment to our 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 1 fund |
| ANAVEX LIFE SCIENCES CORP. | June 10, 2025 | To approve an amendment to the Company's 2022 Omnibus Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 1 fund |
| ANDERSONS INC. | May 8, 2025 | An advisory vote on executive compensation, approving the resolution provided in the proxy statement. Say-on-Pay |
Board | For | FOR 31 funds |
AGAINST 9 funds |
| ANGIODYNAMICS INC. | November 12, 2024 | Approval of an amendment to increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 3 funds |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 4 funds |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 5 funds |
| ANIKA THERAPEUTICS INC. | June 20, 2025 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 7 funds |
| ANIKA THERAPEUTICS INC. | June 20, 2025 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 6 funds |
| ANNEXON INC. | June 5, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 4 funds |
| ANTERIX INC. | August 6, 2024 | To approve Amendment No. 1 to the Anterix Inc. 2023 Stock Plan to increase the number of shares available for issuance under the plan and clarify certain vesting restriction provisions. Compensation |
Board | For | FOR 12 funds |
AGAINST 1 fund |
| ANTERIX INC. | August 6, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 2 funds |
| ANTERO MIDSTREAM CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 46 funds |
AGAINST 11 funds |
| ANTERO RESOURCES CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 44 funds |
AGAINST 7 funds |
| ANYWHERE REAL ESTATE INC. | May 7, 2025 | Approval of the Third Amended and Restated 2018 Long-Term Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| AON PLC | June 27, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 70 funds |
AGAINST 6 funds |
| AON PLC | June 27, 2025 | Approve the Aon plc 2011 Incentive Plan, as amended and restated and increase the number of shares available for issuance. Compensation |
Board | For | FOR 50 funds |
AGAINST 5 funds |
| APA CORP. | May 22, 2025 | Advisory Vote to Approve Compensation of APA's Named Executive Officers Say-on-Pay |
Board | For | FOR 38 funds |
AGAINST 10 funds |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | June 10, 2025 | To conduct an advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 33 funds |
AGAINST 2 funds |
| API GROUP | May 16, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | Not determined | FOR 32 funds |
AGAINST 5 funds |
| APPIAN CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 3 funds |
| APPLE HOSPITALITY REIT INC. | May 19, 2025 | Approval on an advisory basis of executive compensation paid by the Company. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 2 funds |
| APPLIED OPTOELECTRONICS INC. | June 12, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 1 fund |
| APTARGROUP | May 7, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | Not determined | FOR 41 funds |
AGAINST 7 funds |
| APTARGROUP | May 7, 2025 | Approval of an amendment to the 2018 Equity Incentive Plan. Compensation |
Board | Not determined | FOR 26 funds |
AGAINST 6 funds |
| AQUESTIVE THERAPEUTICS INC. | June 11, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 1 fund |
| ARAMARK | January 24, 2025 | To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 40 funds |
AGAINST 6 funds |
| ARBONIA AG | April 25, 2025 | Reelect Michael Pieper as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| ARBONIA AG | April 25, 2025 | Reelect Thomas Lozser as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| ARCELLX INC. | May 28, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | FOR 35 funds |
AGAINST 2 funds |
| ARCH CAPIT | May 7, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | Not determined | FOR 62 funds |
AGAINST 11 funds |
| ARCOSA INC. | May 14, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 3 funds |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 6, 2025 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | FOR 27 funds |
AGAINST 4 funds |
| ARCUTIS BIOTHERAPEUTICS INC. | June 12, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 5 funds |
| ARDENT HEA | May 21, 2025 | Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. Say-on-Pay |
Board | Not determined | FOR 17 funds |
AGAINST 2 funds |
| ARISE AB | May 7, 2025 | Reelect Joachim Gahm (Chair), Johan Damne, Mikael Schoultz and P-G Persson as Directors; Elect Erik Rune and Mia Bodin as New Directors; Ratify PricewaterhouseCoopers as Auditor Director Elections |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| ARKO CORP. | June 5, 2025 | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 5 funds |
| ARLO TECHNOLOGIES INC. | June 20, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 2 funds |
| ARQ INC. | June 3, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion as set forth under the Executive Compensation section of the proxy statement for the 2025 Annual Meeting of Stockholders. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| ARRAY TECHNOLOGIES INC. | May 20, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 7 funds |
| ARTISAN PARTNERS ASSET MANAGEMENT INC | June 4, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 4 funds |
| ARTIVION INC. | May 13, 2025 | To approve additional funding of 3,570,000 shares for the Amended and Restated Artivion, Inc. 2020 Equity and Cash Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 2 funds |
| ARTIVION INC. | May 13, 2025 | To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 3 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 5 funds |
| ASCENT INDUSTRIES CO. | June 25, 2025 | Advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| ASOS PLC | January 22, 2025 | Re-elect Jorgen Lindemann as Director Director Elections |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ASOS PLC | January 22, 2025 | Re-elect Marie Gulin-Merle as Director Director Elections |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ASOS PLC | January 22, 2025 | Re-elect Natasja Laheij as Director Director Elections |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ASOS PLC | January 22, 2025 | Re-elect Wei Gao as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| ASSEMBLY BIOSCIENCES INC. | June 5, 2025 | Approval of an additional amendment to our Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder by 225,000 shares to support a broad-based supplemental retention grant program. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ASSEMBLY BIOSCIENCES INC. | June 5, 2025 | Approval of an amendment to our Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder by 375,000 shares. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ASSEMBLY BIOSCIENCES INC. | June 5, 2025 | Approval, on a non-binding advisory basis, of our named executive officers' compensation. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| ASSOCIATED | April 29, 2025 | Approval of the Associated Banc-Corp 2025 Equity Incentive Plan. Compensation |
Board | Not determined | FOR 17 funds |
AGAINST 5 funds |
| AST SPACEMOBILE INC. | June 6, 2025 | To approve a non-binding advisory vote on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 2 funds |
| ASTRANA HEALTH INC. | June 11, 2025 | To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 5 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 3 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval, by non-binding advisory vote, of our executive compensation. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 4 funds |
| ASTRONICS CORP. | May 22, 2025 | To approve an amendment of the Amended and Restated 2017 Long Term Incentive Plan (the "2017 LTIP") to increase the number of shares available for issuance under the 2017 LTIP. Compensation |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| ASURE SOFTWARE INC. | June 2, 2025 | To approve an amendment to the Asure Software, Inc. 2018 Incentive Award Plan to increase the number of shares of our common stock authorized for issuance by 2,250,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| AT&T | May 15, 2025 | Advisory Approval of Executive Compensation Say-on-Pay |
Board | Not determined | FOR 66 funds |
AGAINST 10 funds |
| ATEA PHARMACEUTICALS INC. | June 20, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 5 funds |
| ATLANTIC U | May 6, 2025 | To approve the Atlantic Union Bankshares Corporation 2025 Stock and Incentive Plan Compensation |
Board | Not determined | FOR 14 funds |
AGAINST 7 funds |
| ATLAS COPCO A | April 29, 2025 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | Not determined | AGAINST 51 funds |
FOR 5 funds |
| ATLAS COPCO A | April 29, 2025 | REELECT ANNA OHLSSON-LEIJON AS DIRECTOR Director Elections |
Board | Not determined | AGAINST 34 funds |
FOR 5 funds |
| ATLAS COPCO A | April 29, 2025 | REELECT JOHAN FORSSELL AS DIRECTOR Director Elections |
Board | Not determined | FOR 34 funds |
AGAINST 5 funds |
| ATLASSIAN CORP PLC | December 11, 2024 | An advisory vote to approve the compensation of our named executive officers for the fiscal year ended June 30, 2024. Say-on-Pay |
Board | Not determined | FOR 65 funds |
AGAINST 8 funds |
| ATMOS ENERGY CORP. | February 5, 2025 | Proposal to approve an amendment to the Company's 1998 Long - Term Incentive Plan to provide for an increase of 2,000,000 shares of common stock reserved for issuance under the plan. Compensation |
Board | For | FOR 36 funds |
AGAINST 13 funds |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Moritz Zimmermann to the Supervisory Board Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA | April 29, 2025 | Reelect Beatriz Roger Torres as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA | April 29, 2025 | Reelect Rosa Maria Lleal Tost as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| ATRICURE INC. | May 19, 2025 | Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,700,000. Compensation |
Board | For | FOR 14 funds |
AGAINST 1 fund |
| ATTENDO AB | May 7, 2025 | Reelect Tobias Lonnevall as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| ATTENDO AB | May 7, 2025 | Reelect Ulf Mattsson (Chair) as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| ATYR PHARMA INC. | May 1, 2025 | To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended; and Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AURINIA PHARMACEUTICALS INC. | May 15, 2025 | Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 4 funds |
| AUTODESK | June 18, 2025 | Amend and restate the 2022 Equity Incentive Plan. Compensation |
Board | For | FOR 69 funds |
AGAINST 5 funds |
| AUTOLIV INC. | May 8, 2025 | Advisory vote on Autoliv, Inc.'s 2024 Executive Compensation. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 10 funds |
| AVANOS MEDICAL INC. | April 24, 2025 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| AVANZA BANK HOLDING AB | April 24, 2025 | Reelect John Hedberg as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| AVANZA BANK HOLDING AB | April 24, 2025 | Reelect John Hedberg as Vice Chair Director Elections |
Board | For | FOR 7 funds |
AGAINST 6 funds |
← Previous Page 2 of 24 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.